Quarterly report pursuant to Section 13 or 15(d)

ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)

v3.21.2
ORGANIZATION, OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
May 21, 2020
Mar. 23, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Research and development costs     $ 566,655 $ 152,123 $ 1,052,650 $ 309,403  
Impairment loss         39,434 25,320,555  
Loss from operation     (1,663,111) $ (695,978) (3,944,813) (27,175,215) $ (25,359,989)
Depreciation         3,978 5,083  
Excess of the FDIC insured limits     1,934,969   1,934,969   $ 1,934,969
Advertising and marketing costs         $ 70,692 $ 70,198  
Valuation allowance, percentage         100.00%   100.00%
FDIC insured limit     $ 250,000   $ 250,000    
Ownership interest, percentage     1.38%   1.38%   1.38%
Common stock, shares authorized     100,000,000   100,000,000   100,000,000
Common stock, par value     $ 0.00001   $ 0.00001   $ 0.00001
Annual Meeting of Shareholders [Member]              
Common stock, shares authorized   100,000,000 800,000,000   800,000,000    
Common stock, par value   $ 0.00001 $ 0.00001   $ 0.00001    
Description of reverse stock split The effective dates of the above actions were June 5, 2020 and April 20, 2020, respectively, and the actual reverse stock split ratio was 1-for-33.26 reverse stock split of the Company’s outstanding common stock at a ratio between 1-for-32 and 1-for-35 (with the exact ratio to be determined by the directors in their sole discretion without further approval by the shareholders